The American Hospital Association revealed late Tuesday (Sept. 20) that FDA has agreed to report to plans and providers the high-risk implantable devices it intends to monitor using unique device identifiers, and that ASC X12, the standards organization tasked with incorporating UDIs in claims forms, voted late Monday (Sept. 19) to advance the process of incorporating UDIs in claims. “As urged by the AHA, X12 voted last night on a solution for reporting the new unique device identifier on health...